Franciosi, Lui G <br/><br/>
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.  [electronic resource] 

 -  The Lancet. Respiratory medicine  Nov 2013 
 - 714-27 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-2600 
<br/><br/><label>Standard No.: </label>10.1016/S2213-2600(13)70187-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adult<br/>Aged<br/>Asthma--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Forced Expiratory Volume--drug effects<br/>Healthy Volunteers<br/>Humans<br/>Isoquinolines--administration & dosage<br/>Male<br/>Middle Aged<br/>Nebulizers and Vaporizers<br/>Phosphodiesterase 3 Inhibitors--administration & dosage<br/>Phosphodiesterase 4 Inhibitors--administration & dosage<br/>Prospective Studies<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Pyrimidinones--administration & dosage<br/>Single-Blind Method<br/>Treatment Outcome<br/>Young Adult